IPCA Laboratories
Nitin Chandurkar is an experienced professional in the pharmaceutical industry, currently holding the position of Senior Vice President Global Clinical Research and Development at Ipca Laboratories Limited. With a strong background in clinical research and development, Nitin has previously worked in various leadership roles at companies like Amneal Pharmaceuticals, Dr. Reddy's Laboratories Ltd, and Dabur India Limited. NITIN holds a M Pharm in Advanced Pharmaceutical Sciences from Birla Institute of Technology and Science and a B Pharm in Pharmaceutical Sciences from Institute of Pharmaceutical Education and Research. Their expertise lies in overseeing clinical research activities for Generics, Biosimilars, NCEs, Repurposed Drugs for various regulated markets.
This person is not in any teams
IPCA Laboratories
3 followers
Ipca Laboratories Limited is engaged in pharmaceuticals business. The Company is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs). It offers APIs, such as atenolol, hydroxychloroquine sulfate, morantel citrate, pyrantel pamoate and zaltoprofen. It offers brands, such as Zerodol, Lariago, HCQS Perinorm, Rapither, Tenoric, Lumerax, Etova, Malirid and Folitrax. Its 3c division focuses on cardiovascular and anti-diabetic markets. Its 3d division is focused on cardio-diabetic market. The Company's activa division serves the rheumatology market. Its altus division caters to the needs of intensivists, both surgical and non-surgical. Its Bionova division's focus area is dermatology. Its dynamix division focuses on cardiovascular, gastro-intestinal, anti-bacterial, pain management and respiratory sectors. It hycare division caters to the needs of cardiologists and diabetologists. Its divisions also include innova, intima, pain management, pharma and uro sciences.